gyki 52466 has been researched along with Acute Disease in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Acute Disease: Disease having a short and relatively severe course.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elger, B | 1 |
| Huth, A | 1 |
| Neuhaus, R | 1 |
| Ottow, E | 1 |
| Schneider, H | 1 |
| Seilheimer, B | 1 |
| Turski, L | 1 |
1 other study available for gyki 52466 and Acute Disease
| Article | Year |
|---|---|
Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration.
Topics: Acute Disease; Animals; Benzodiazepines; Binding, Competitive; Brain Infarction; Cells, Cultured; Di | 2005 |